BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7877583)

  • 21. Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications.
    Aderka D
    Isr J Med Sci; 1991 Jan; 27(1):52-60. PubMed ID: 1995504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical relevance of determination of plasma ATIII and alpha 2 PI activities in patients with DIC--application of the molecular markers for the analysis of pathophysiology of DIC].
    Okajima K
    Rinsho Byori; 1994 Jan; 42(1):45-55. PubMed ID: 8107283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel platelet activating factor antagonist, SM-12502, attenuates endotoxin-induced disseminated intravascular coagulation and acute pulmonary vascular injury by inhibiting TNF production in rats.
    Murakami K; Okajima K; Uchiba M; Johno M; Okabe H; Takatsuki K
    Thromb Haemost; 1996 Jun; 75(6):965-70. PubMed ID: 8822594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical aspects of DIC--disseminated intravascular coagulation.
    Matsuda T
    Pol J Pharmacol; 1996; 48(1):73-5. PubMed ID: 9112631
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
    Matsuo T; Matsuo M; Sugimoto T; Wanaka K
    Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988.
    Imura Y; Terashita Z; Nishikawa K
    Life Sci; 1986 Jul; 39(2):111-7. PubMed ID: 3741541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
    Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
    Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma antigen levels of thrombin-activatable fibrinolysis inhibitor did not differ in patients with or without disseminated intravascular coagulation.
    Chen CC; Lee KD; Gau JP; Yu YB; You JY; Lee SC; Hsu HC; Chau WK; Ho CH
    Ann Hematol; 2005 Oct; 84(10):675-80. PubMed ID: 16007424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Severe surgical infection and DIC].
    Tamakuma S
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):878-81. PubMed ID: 6427596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disseminated intravascular coagulation (DIC) in rabbit haemorrhagic disease.
    Ueda K; Park JH; Ochiai K; Itakura C
    Jpn J Vet Res; 1992 Dec; 40(4):133-41. PubMed ID: 1338394
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated intravascular coagulation: What's new?
    Levi M
    Crit Care Clin; 2005 Jul; 21(3):449-67. PubMed ID: 15992667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibronectin and other DIC-related variables in septic ICU patients receiving cryoprecipitate.
    Hesselvik F; Brodin B; Blombäck M; Cedergren B; Lieden G; Maller R
    Scand J Clin Lab Invest Suppl; 1985; 178():67-74. PubMed ID: 3937220
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.
    Kushimoto S; Gando S; Saitoh D; Ogura H; Mayumi T; Koseki K; Ikeda T; Ishikura H; Iba T; Ueyama M; Eguchi Y; Otomo Y; Okamoto K; Endo S; Shimazaki S;
    Thromb Haemost; 2008 Dec; 100(6):1099-105. PubMed ID: 19132236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasmapheresis in the treatment of severe meningococcal or pneumococcal septicaemia with DIC and fibrinolysis. Preliminary data on eight patients.
    Brandtzaeg P; Sirnes K; Folsland B; Godal HC; Kierulf P; Bruun JN; Dobloug J
    Scand J Clin Lab Invest Suppl; 1985; 178():53-5. PubMed ID: 3867122
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
    Levi M
    J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of DIC in multiple organ failure.
    Kidokoro A; Iba T; Hong J
    Int J Surg Investig; 2000; 2(1):73-80. PubMed ID: 12774341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
    Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
    Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is activated C3 a premier factor of DIC development in septic shock?
    Wu QX; Liu ZY; Dang Y; Chen L; Chen HC
    Prog Clin Biol Res; 1989; 308():271-5. PubMed ID: 2675052
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravascular coagulation and reticuloendothelial depression in septic sheep.
    Kashtan J; Blaisdell FW; Lin HJ; Zaiss C
    Adv Shock Res; 1982; 7():173-7. PubMed ID: 6753531
    [No Abstract]   [Full Text] [Related]  

  • 40. Measurement of thrombus precursor protein in septic patients with disseminated intravascular coagulation and liver disease.
    Song KS; Kim HK; Song JW
    Haematologica; 2002 Oct; 87(10):1062-7. PubMed ID: 12368161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.